ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.
| # | Date | Company | Ticker | CUSIP | Weight | Shares Held | Market Value |
|---|---|---|---|---|---|---|---|
| 1 | 03/18/2025 | TWIST BIOSCIENCE CORP | TWST | 90184D100 | 8.81% | 2,293,068 (0) (0%) | $97,088,499.12 |
| 2 | 03/18/2025 | CRISPR THERAPEUTICS AG | CRSP | H17182108 | 8.08% | 2,079,923 (0) (0%) | $89,062,302.86 |
| 3 | 03/18/2025 | RECURSION PHARMACEUTICALS-A | RXRX | 75629V104 | 7.90% | 12,725,971 (0) (0%) | $87,045,641.64 |
| 4 | 03/18/2025 | TEMPUS AI INC | TEM | 88023B103 | 7.17% | 1,584,889 (0) (0%) | $79,038,414.43 |
| 5 | 03/18/2025 | NATERA INC | NTRA | 632307104 | 5.52% | 407,535 (0) (0%) | $60,824,598.75 |
| 6 | 03/18/2025 | GUARDANT HEALTH INC | GH | 40131M109 | 5.49% | 1,411,025 (0) (0%) | $60,532,972.50 |
| 7 | 03/18/2025 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 00650F109 | 5.30% | 7,742,730 (0) (0%) | $58,380,184.20 |
| 8 | 03/18/2025 | SCHRODINGER INC | SDGR | 80810D103 | 4.94% | 2,293,736 (0) (0%) | $54,430,355.28 |
| 9 | 03/18/2025 | BEAM THERAPEUTICS INC | BEAM | 07373V105 | 4.41% | 1,982,170 (0) (0%) | $48,602,808.40 |
| 10 | 03/18/2025 | CAREDX INC | CDNA | 14167L103 | 4.10% | 2,345,036 (0) (0%) | $45,188,843.72 |
| 11 | 03/18/2025 | VERACYTE INC | VCYT | 92337F107 | 3.68% | 1,299,929 (0) (0%) | $40,596,782.67 |
| 12 | 03/18/2025 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | 3.11% | 1,000,125 (0) (0%) | $34,304,287.50 |
| 13 | 03/18/2025 | 10X GENOMICS INC-CLASS A | TXG | 88025U109 | 2.94% | 3,016,173 (0) (0%) | $32,454,021.48 |
| 14 | 03/18/2025 | ABSCI CORP | ABSI | 00091E109 | 2.82% | 9,685,577 (0) (0%) | $31,090,702.17 |
| 15 | 03/18/2025 | ARCTURUS THERAPEUTICS HOLDIN | ARCT UQ | 03969T109 | 2.58% | 2,009,031 (0) (0%) | $28,447,878.96 |
| 16 | 03/18/2025 | INTELLIA THERAPEUTICS INC | NTLA | 45826J105 | 2.56% | 2,947,494 (103,955) (3.66%) | $28,236,992.52 |
| 17 | 03/18/2025 | PERSONALIS INC | PSNL | 71535D106 | 2.48% | 7,186,995 (0) (0%) | $27,310,581.00 |
| 18 | 03/18/2025 | NURIX THERAPEUTICS INC | NRIX | 67080M103 | 2.01% | 1,588,737 (0) (0%) | $22,131,106.41 |
| 19 | 03/18/2025 | AMGEN INC | AMGN | 031162100 | 1.79% | 62,125 (-6,807) (-9.87%) | $19,704,186.25 |
| 20 | 03/18/2025 | BUTTERFLY NETWORK INC | BFLY | 124155102 | 1.74% | 7,018,202 (0) (0%) | $19,229,873.48 |
| 21 | 03/18/2025 | ILLUMINA INC | ILMN | 452327109 | 1.67% | 215,448 (0) (0%) | $18,459,584.64 |
| 22 | 03/18/2025 | VEEVA SYSTEMS INC-CLASS A | VEEV | 922475108 | 1.47% | 68,345 (0) (0%) | $16,195,031.20 |
| 23 | 03/18/2025 | PACIFIC BIOSCIENCES OF CALIF | PACB | 69404D108 | 1.33% | 11,817,426 (0) (0%) | $14,653,608.24 |
| 24 | 03/18/2025 | QUANTUM-SI INC | QSI | 74765K105 | 1.30% | 8,710,647 (0) (0%) | $14,372,567.55 |
| 25 | 03/18/2025 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | 1.23% | 26,288 (0) (0%) | $13,505,722.88 |
| 26 | 03/18/2025 | 908 DEVICES INC | MASS | 65443P102 | 1.20% | 2,897,771 (0) (0%) | $13,271,791.18 |
| 27 | 03/18/2025 | CERUS CORP | CERS | 157085101 | 1.00% | 7,610,690 (0) (0%) | $11,035,500.50 |
| 28 | 03/18/2025 | INCYTE CORP | INCY | 45337C102 | 0.94% | 167,857 (0) (0%) | $10,408,812.57 |
| 29 | 03/18/2025 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | 0.84% | 13,674 (0) (0%) | $9,276,715.08 |
| 30 | 03/18/2025 | COMPASS PATHWAYS PLC | CMPS | 20451W101 | 0.57% | 1,804,353 (0) (0%) | $6,243,061.38 |
| 31 | 03/18/2025 | PRIME MEDICINE INC | PRME | 74168J101 | 0.40% | 2,539,700 (0) (0%) | $4,444,475.00 |
| 32 | 03/18/2025 | STANDARD BIOTOOLS INC | LAB | 34385P108 | 0.37% | 3,451,595 (0) (0%) | $4,038,366.15 |
| 33 | 03/18/2025 | REPARE THERAPEUTICS INC | RPTX | 760273102 | 0.16% | 1,601,774 (-50,241) (-3.04%) | $1,818,013.49 |
| 34 | 03/18/2025 | GOLDMAN FS TRSY OBLIG INST 468 | X9USDGSFT | 0.08% | 838,544 (798,131) (1974.94%) | $838,543.53 |
Discover more from ARK Invest Daily Trades Tracker
Subscribe to get the latest posts sent to your email.
